Skip to content

Portal Hypertension Using Magnetic Resonance Elastography

Non-invasive Assessment of Portal Hypertension Using Quantitative Magnetic Resonance Imaging

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05749198
Enrollment
47
Registered
2023-03-01
Start date
2018-01-02
Completion date
2023-01-28
Last updated
2023-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Portal Hypertension, Magnetic Resonance Imaging

Brief summary

This prospective study was conducted in a tertiary university hospital. The investigators researched the correlation between MRE-assessed stiffness of the liver and spleen and the Hepatic venous pressure gradient (HVPG) values. Furthermore, the investigator evaluated whether MRE-assessed stiffness reflected changes in portal hypertension (PH) after administering non-selective beta-blockers (NSBBs).

Interventions

DIAGNOSTIC_TESTMRE

MRE was performed using a 3T system (Magnetom Skyra; Siemens, Erlangen, Germany) equipped with a combination of a 30-channel body and a 32-channel spine matrix coil.

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* diagnosed liver cirrhosis * requiring prophylactic treatment of esophageal varices

Exclusion criteria

* the coexistence of hepatocellular carcinoma * refractory ascites who regularly underwent large-volume paracentesis * the use of selective beta-blocker or carvedilol therapy for at least 4 weeks * undergoing liver transplantation * contraindication with magnetic resonance imaging

Design outcomes

Primary

MeasureTime frame
Change of liver stiffness and spleen stiffness by MREChange from baseline stiffness of MRE at 6 months
The change of portal pressure (HVPG) prior to and after treatment with NSBBChange from baseline and at 6 months

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026